Penumbra's Indigo Thrombectomy Aspiration System Studied in Acutely Thrombosed Dialysis Arteriovenous Fistulas and Grafts


June 7, 2018—Clément Marcelin, MD, et al reported findings from a multicenter study that sought to analyze technical and clinical outcomes of percutaneous thrombectomy aspiration using a vacuum-assisted thrombectomy catheter in acutely thrombosed dialysis arteriovenous fistulas (AVFs) and/or arteriovenous grafts (AVGs). The study's results are available online in Journal of Vascular and Interventional Radiology (JVIR).

The study was composed of 35 patients (average age, 61.8 years; range, 33–81 years) presenting with acute thrombosis of a dialysis AVF and/or AVG from June 2016 to April 2017. Investigators prospectively evaluated patients treated by mechanical thrombectomy using the Indigo system (Penumbra, Inc.) and noted adjunctive therapies and procedure-related complications. They assessed technical success, clinical success, primary patency, primary assisted patency, and secondary patency of the dialysis fistula.

As summarized in JVIR, mean follow-up time in the study was 8.5 months (range, 3–12 months). Technical success was 97.1% (34/35 patients). Clinical success was 91.4% (32/35 patients). Complications included hematoma (n = 1), thrombosis < 24 hours (n = 1), and perforation (n = 1).

Other mechanical/aspiration thrombectomy devices were used in one site to clear the thrombus burden: Arrow-Trerotola (Teleflex, Inc.; 2.8% [1/35 patients]) and Fogarty (Edwards Lifesciences; 5.7% [2/35 patients]). The average procedure time was 38.1 minutes (range, 15–140 min). Average blood loss during the procedure was 122.5 mL (range, 50–300 mL). The 6-month primary patency, primary assisted patency, and secondary patency rates were 71%, 80%, and 88.5%, respectively. No risk factors for early dialysis fistula occlusion were identified. There was no 30-day mortality, reported the investigators.

Percutaneous mechanical thrombectomy aspiration of thrombosed dialysis AVFs and/or AVGs with a vacuum-assisted thrombectomy catheter is a safe procedure with a low complication rate and an effective method for restoring patency before hemodialysis, concluded the investigators in JVIR.


Contact Info

For advertising rates and opportunities, contact:
Craig McChesney

Stephen Hoerst

Charles Philip

About Endovascular Today

Endovascular Today is a publication dedicated to bringing you comprehensive coverage of all the latest technology, techniques, and developments in the endovascular field. Our Editorial Advisory Board is composed of the top endovascular specialists, including interventional cardiologists, interventional radiologists, vascular surgeons, neurologists, and vascular medicine practitioners, and our publication is read by an audience of more than 22,000 members of the endovascular community.